{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:32:31Z","timestamp":1790562751083,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF15CC0018346"],"award-info":[{"award-number":["NNF15CC0018346"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF15CC0018486"],"award-info":[{"award-number":["NNF15CC0018486"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["10350"],"award-info":[{"award-number":["10350"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.prostaglandins.2018.09.007","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T20:20:58Z","timestamp":1537561258000},"page":"24-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Targeting cysteinyl-leukotrienes in abdominal aortic aneurysm"],"prefix":"10.1016","volume":"139","author":[{"given":"Ana Carolina","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Z.","family":"Haeggstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.007_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001513","article-title":"Risk profiles for aortic dissection and ruptured or surgically treated aneurysms: a prospective cohort study","volume":"4","author":"Landenhed","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"22","key":"10.1016\/j.prostaglandins.2018.09.007_bib0010","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMcp1401430","article-title":"Clinical practice. Abdominal aortic aneurysms","volume":"371","author":"Kent","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.09.007_bib0015","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.CIR.0000154569.08857.7A","article-title":"Thoracic and abdominal aortic aneurysms","volume":"111","author":"Isselbacher","year":"2005","journal-title":"Circ"},{"issue":"8","key":"10.1016\/j.prostaglandins.2018.09.007_bib0020","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/bjs.9838","article-title":"Age-specific incidence, risk factors and outcome of acute abdominal aortic aneurysms in a defined population","volume":"102","author":"Howard","year":"2015","journal-title":"Br. J. Surg."},{"issue":"8923","key":"10.1016\/j.prostaglandins.2018.09.007_bib0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(94)92087-7","article-title":"Smoking and growth rate of small abdominal aortic aneurysms","volume":"344","author":"MacSweeney","year":"1994","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.prostaglandins.2018.09.007_bib0030","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/ATVBAHA.112.300158","article-title":"Understanding the effects of tobacco smoke on the pathogenesis of aortic aneurysm","volume":"33","author":"Norman","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.09.007_bib0035","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.avsg.2013.11.005","article-title":"Family members of patients with abdominal aortic aneurysms are at increased risk for aneurysms: analysis of 618 probands and their families from the Liege AAA Family Study","volume":"28","author":"Sakalihasan","year":"2014","journal-title":"Ann. Vasc. Surg."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.007_bib0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jvs.2012.01.061","article-title":"High prevalence of abdominal aortic aneurysms in brothers and sisters of patients despite a low prevalence in the population","volume":"56","author":"Linne","year":"2012","journal-title":"J. Vasc. Surg."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.09.007_bib0045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jvs.2010.05.090","article-title":"Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals","volume":"52","author":"Kent","year":"2010","journal-title":"J. Vasc. Surg."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.09.007_bib0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.ATV.0000214999.12921.4f","article-title":"Inflammation and cellular immune responses in abdominal aortic aneurysms","volume":"26","author":"Shimizu","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.09.007_bib0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0741-5214(03)00324-0","article-title":"Current concepts in the pathogenesis of abdominal aortic aneurysm","volume":"38","author":"Ailawadi","year":"2003","journal-title":"J. Vasc. Surg."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.09.007_bib0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jbiomech.2011.11.021","article-title":"Mechanics, mechanobiology, and modeling of human abdominal aorta and aneurysms","volume":"45","author":"Humphrey","year":"2012","journal-title":"J. Biomech."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.09.007_bib0065","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1358\/dnp.2008.21.3.1203410","article-title":"Basic research studies to understand aneurysm disease","volume":"21","author":"Boddy","year":"2008","journal-title":"Drug news perspec"},{"issue":"9","key":"10.1016\/j.prostaglandins.2018.09.007_bib0070","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1586\/14779072.2015.1074861","article-title":"Understanding the pathogenesis of abdominal aortic aneurysms","volume":"13","author":"Kuivaniemi","year":"2015","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.09.007_bib0075","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jvs.2010.01.057","article-title":"The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms","volume":"51","author":"Abdul-Hussien","year":"2010","journal-title":"J. Vasc. Surg."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.09.007_bib0080","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.ATV.0000257552.94483.14","article-title":"Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms","volume":"27","author":"McCormick","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.09.007_bib0085","first-page":"215","article-title":"MicroRNAs and current concepts on the pathogenesis of abdominal aortic aneurysm","volume":"32","author":"Joviliano","year":"2017","journal-title":"Braz. J. Cardiovasc. Surg."},{"issue":"8","key":"10.1016\/j.prostaglandins.2018.09.007_bib0090","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/ATVBAHA.115.305269","article-title":"Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy","volume":"35","author":"Dale","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.prostaglandins.2018.09.007_bib0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/eji.1830270125","article-title":"Human Th1 cells preferentially induce interleukin (IL)-lb while Th2 cells induce IL-1 receptor antagonist production upon cell\/cell contact with monocytes","volume":"1","author":"Chizzolini","year":"1997","journal-title":"Eur. J. Immunogenet."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.007_bib0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1172\/JCI22309","article-title":"Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context?","volume":"114","author":"Curci","year":"2004","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.007_bib0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/cvr\/cvt040","article-title":"Biomechanical factors in the biology of aortic wall and aortic valve diseases","volume":"99","author":"Back","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.007_bib0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jvs.2010.12.053","article-title":"Analysis of aortic wall stress and rupture risk in patients with abdominal aortic aneurysm with a gender perspective","volume":"54","author":"Larsson","year":"2011","journal-title":"J. Vasc. Surg."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.09.007_bib0115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4168\/aair.2014.6.4.288","article-title":"Cysteinyl leukotrienes and their receptors; emerging concepts","volume":"6","author":"Kanaoka","year":"2014","journal-title":"Allergy Asthma Immunol. Res."},{"issue":"10","key":"10.1016\/j.prostaglandins.2018.09.007_bib0120","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1021\/cr100392s","article-title":"Leukotriene receptors","volume":"111","author":"Nakamura","year":"2011","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.007_bib0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2010.03.140","article-title":"Advances in eicosanoid research, novel therapeutic implications","volume":"396","author":"Haeggstrom","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"22","key":"10.1016\/j.prostaglandins.2018.09.007_bib0130","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1161\/CIRCULATIONAHA.107.747667","article-title":"Multidrug resistance protein-1 affects oxidative stress, endothelial dysfunction, and atherogenesis via leukotriene C4 export","volume":"117","author":"Mueller","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.prostaglandins.2018.09.007_bib0135","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrd1796","article-title":"Leukotriene modifiers as potential therapeutics for cardiovascular disease","volume":"4","author":"Funk","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.prostaglandins.2018.09.007_bib0140","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstrom","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.prostaglandins.2018.09.007_bib0145","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/490968","article-title":"Leukotrienes as modifiers of preclinical atherosclerosis?","volume":"2012","author":"Riccioni","year":"2012","journal-title":"Sci. World J."},{"key":"10.1016\/j.prostaglandins.2018.09.007_bib0150","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2432958","article-title":"Role of the cysteinyl leukotrienes in the pathogenesis and progression of cardiovascular diseases","volume":"2017","author":"Colazzo","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"49","key":"10.1016\/j.prostaglandins.2018.09.007_bib0155","doi-asserted-by":"crossref","first-page":"21093","DOI":"10.1073\/pnas.1015166107","article-title":"Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm","volume":"107","author":"Di Gennaro","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.prostaglandins.2018.09.007_bib0160","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1073\/pnas.1717906115","article-title":"Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm","volume":"115","author":"Di Gennaro","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.09.007_bib0165","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1096\/fj.08-116202","article-title":"Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus","volume":"23","author":"Houard","year":"2009","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.09.007_bib0170","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/pr.58.3.8","article-title":"Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses","volume":"58","author":"Folco","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"20","key":"10.1016\/j.prostaglandins.2018.09.007_bib0175","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1073\/pnas.0903851106","article-title":"Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation","volume":"106","author":"Zarini","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.prostaglandins.2018.09.007_bib0180","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.prostaglandins.2018.09.007_bib0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","article-title":"Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways","volume":"25","author":"Serhan","year":"2007","journal-title":"Annu. Rev. Immunol."},{"issue":"6738","key":"10.1016\/j.prostaglandins.2018.09.007_bib0190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene CysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.09.007_bib0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM199901213400306","article-title":"Treatment of asthma with drugs modifyng the leukotriene pathway","volume":"340","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.09.007_bib0200","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1124\/mol.53.4.750","article-title":"Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma","volume":"53","author":"Capra","year":"1998","journal-title":"J. Mol. Pharm. Org. Process Res."},{"issue":"9","key":"10.1016\/j.prostaglandins.2018.09.007_bib0205","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1074\/jbc.273.9.4878","article-title":"Leukotriene D4 activates mitogen-activated protein kinase through a protein kinase Calpha-Raf-1-dependent pathway in human monocytic leukemia THP-1 cells","volume":"273","author":"Hoshino","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"39","key":"10.1016\/j.prostaglandins.2018.09.007_bib0210","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","article-title":"Characterization of the human cysteinyl leukotriene 2 receptor","volume":"275","author":"Heise","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.007_bib0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/bbrc.2000.3140","article-title":"The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor","volume":"274","author":"Takasaki","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.09.007_bib0220","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1124\/mol.58.6.1601","article-title":"Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist","volume":"58","author":"Nothacker","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.09.007_bib0225","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1006\/bbrc.2001.5695","article-title":"Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells","volume":"287","author":"Kamohara","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.prostaglandins.2018.09.007_bib0230","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1161\/01.ATV.0000082689.46538.DF","article-title":"Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells","volume":"23","author":"Sjostrom","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.09.007_bib0235","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.ajpath.2011.02.041","article-title":"Characterization of the cysteinyl leukotriene 2 receptor in novel expression sites of the gastrointestinal tract","volume":"178","author":"Barajas-Espinosa","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.prostaglandins.2018.09.007_bib0240","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1096\/fj.10-177030","article-title":"Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT2 receptor","volume":"25","author":"Carnini","year":"2011","journal-title":"FASEB J."},{"issue":"20","key":"10.1016\/j.prostaglandins.2018.09.007_bib0245","doi-asserted-by":"crossref","first-page":"11589","DOI":"10.1073\/pnas.2034927100","article-title":"Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R","volume":"100","author":"Mellor","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"43","key":"10.1016\/j.prostaglandins.2018.09.007_bib0250","doi-asserted-by":"crossref","first-page":"16695","DOI":"10.1073\/pnas.0808993105","article-title":"Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors","volume":"105","author":"Maekawa","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prostaglandins.2018.09.007_bib0255","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMra0804579","volume":"360","author":"Fanta","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.09.007_bib0260","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/CRD.0b013e3181b04698","article-title":"Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm","volume":"17","author":"Rizas","year":"2009","journal-title":"Cardiol. Rev."},{"issue":"7","key":"10.1016\/j.prostaglandins.2018.09.007_bib0265","doi-asserted-by":"crossref","first-page":"952","DOI":"10.15252\/emmm.201303811","article-title":"IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms","volume":"6","author":"Wang","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.09.007_bib0270","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/ATVBAHA.115.306497","article-title":"Asthma associates with human abdominal aortic aneurysm and rupture","volume":"36","author":"Liu","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.007_bib0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/ATVBAHA.115.305911","article-title":"Allergic lung inflammation aggravates angiotensin II-Induced abdominal aortic aneurysms in mice","volume":"36","author":"Liu","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.007_bib0280","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1067\/mva.2000.107562","article-title":"Early inflammatory response after elective abdominal aortic aneurysm repair: a comparison between endovascular procedure and conventional surgery","volume":"32","author":"Galle","year":"2000","journal-title":"J. Vasc. Surg."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.09.007_bib0285","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/ATVBAHA.110.213157","article-title":"Mast cells: important players in the orchestrated pathogenesis of abdominal aortic aneurysms","volume":"31","author":"Swedenborg","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.prostaglandins.2018.09.007_bib0290","first-page":"314","article-title":"Mast cells in abdominal aortic aneurysms","volume":"11","author":"Shi","year":"2013","journal-title":"CurVasc Pharm"},{"issue":"12","key":"10.1016\/j.prostaglandins.2018.09.007_bib0295","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1365-2222.2004.02119.x","article-title":"Biological effects of montelukast, a cysteinyl-leukotriene receptor-antagonist, on T lymphocytes","volume":"34","author":"Spinozzi","year":"2004","journal-title":"Clin. Exp. Allergy"},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.09.007_bib0300","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000312669","article-title":"Cysteinyl leukotrienes and their receptors: molecular and functional characteristics","volume":"85","author":"Singh","year":"2010","journal-title":"Pharmacology"},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.09.007_bib0305","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jaci.2005.12.1329","article-title":"Leukotriene D4 enhances immunoglobulin production in CD40-activated human B lymphocytes","volume":"117","author":"Lamoureux","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.09.007_bib0310","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1165\/rcmb.2005-0407OC","article-title":"CysLT1 receptor engagement induces activator protein-1- and NF-kappaB-dependent IL-8 expression","volume":"35","author":"Thompson","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.prostaglandins.2018.09.007_bib0315","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fcvm.2015.00019","article-title":"The abdominal aortic aneurysm and intraluminal thrombus: current concepts of development and treatment","volume":"2","author":"Piechota-Polanczyk","year":"2015","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.prostaglandins.2018.09.007_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40733-016-0029-3","article-title":"Asthma costs and social impact","volume":"3","author":"Nunes","year":"2017","journal-title":"Asthma Res. Pract."},{"key":"10.1016\/j.prostaglandins.2018.09.007_bib0325","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.2500\/aap.2012.33.3603","article-title":"Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys","volume":"33","author":"Meltzer","year":"2012","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.prostaglandins.2018.09.007_bib0330","series-title":"SINGULAIR\u00ae (Montelukast Sodium) Tablets, Chewable Tablets, and Oral Granules. Data Sheet","author":"Merck","year":"1998"},{"issue":"9","key":"10.1016\/j.prostaglandins.2018.09.007_bib0335","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nm1099","article-title":"The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm","volume":"10","author":"Zhao","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.prostaglandins.2018.09.007_bib0340","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/157016111796197288","article-title":"Doxycycline inhibition of abdominal aortic aneurysm growth \u2013 a systematic review of the literature","volume":"9","author":"Dodd","year":"2011","journal-title":"Curr. Vasc. Pharmcol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.007_bib0345","doi-asserted-by":"crossref","first-page":"45","DOI":"10.12945\/j.aorta.2013.13.002","article-title":"Do beta-blockers really work for prevention of aortic aneurysms? Time for reassessment","volume":"1","author":"Chun","year":"2013","journal-title":"Aorta"},{"issue":"8","key":"10.1016\/j.prostaglandins.2018.09.007_bib0350","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/bjs.9824","article-title":"Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm","volume":"102","author":"Sillesen","year":"2015","journal-title":"Br. J. Surg."},{"issue":"11","key":"10.1016\/j.prostaglandins.2018.09.007_bib0355","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/bjs.7628","article-title":"Reproducibility of ultrasound measurement of the abdominal aorta","volume":"98","author":"Beales","year":"2011","journal-title":"Br. J. Surg."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882318300704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882318300704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:59:14Z","timestamp":1761098354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882318300704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":71,"alternative-id":["S1098882318300704"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.09.007","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting cysteinyl-leukotrienes in abdominal aortic aneurysm","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}